Ariel Alternatives Closes Inaugural $1.45 Billion “Project Black” Fund with Partners and Co-Investors
Capital to create minority-owned businesses of scale, seeking to provide Fortune 500 companies with diverse vendors
Additional co-investor commits up to $200 million for future transactions
One of the largest private equity fund closings for a first-time manager globally
Upfront Note:
AmerisourceBergen, a global healthcare company, has proudly committed $100 million in Project Black, one of the largest first-time private equity funds launched by Ariel Alternatives. Project Black will create minority businesses of scale, providing Fortune 500 companies with diverse vendors while empowering diverse leadership and workforces and creating jobs.
“At AmerisourceBergen, we have a responsibility to lean into our position at the center of the global healthcare industry to positively impact the communities we serve. That responsibility includes how we advance health equity, address social determinants of health and reduce systemic disparities with the goal of moving health forward. At the heart of who we are is our passion for partnership. Investing in Ariel Investments Project Black is a powerful, collective way to advance racial and social equity by creating economic opportunities that will empower communities across the United States,” said Steven H. Collis, Chairman, President & Chief Executive Officer of AmerisourceBergen.
Related content
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.